Schrodinger, Inc. Net Common Equity Issued/Repurchased 2019-2024 | SDGR
Schrodinger, Inc. net common equity issued/repurchased from 2019 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Schrodinger, Inc. Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2023 | $9 |
| 2022 | $2 |
| 2021 | $8 |
| 2020 | $541 |
| 2019 | $1 |
| 2018 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||